Answers are grounded in this paper and cite their sources.
Objective: Microvascular complications (MVC) are a result of endothelial dysfunction in Type-2 diabetes mellitus (T2DM). The relationships between T2DM and MVC and the EDN1 rs5370 and rs1800541 polymorphisms were investigated in this study. Methodology: 220 T2DM patients and 130 healthy controls participated in a case-control study from 20/04/2025 to 31/12/2025. Metabolic indices, circulating endothelin-1 (ET-1), EDN1 rs5370 and rs1800541 polymorphisms, and clinical features were evaluated. Associations and model discrimination were evaluated with receiver operating characteristic (ROC) analysis, but NRI and IDI were employed to assess reclassification. Results: 43 patients (19.5%) had MVC. ET-1 levels were substantially greater in MVC patients than in non-MVC patients (p<0.001). T2DM susceptibility was not linked to either polymorphism. However, both rs5370 and rs1800541 had substantial interactions with ET-1 (p<0.001) and independently associated with MVC. Both polymorphisms considerably increased reclassification. (NRI = 0.42 and 0.50; IDI = 0.11 and 0.14, respectively; all p<0.001) and improved the clinical model (AUC: 0.79 vs. 0.87, p = 0.003). Conclusion: EDN1 rs5370 and rs1800541 were associated with diabetic MVC, especially when paired with circulating ET-1 levels, but they were not linked to T2DM susceptibility. These results validate the use of biochemical and genetic markers for T2DM risk assessment.
No takes yet. Share an insight, caveat, or question.
Ahmed Mohammed Ahmed (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: